Substance Use Tools & Resources    

Provides a sample consent for treatment with buprenorphine/naloxone.

Presents a sample intake questionnaire for patient treatment-planning questions.

This web page outlines policies on substance use during pregnancy, categorizing how these policies differ from state to state.

Maternal Mortality Review Committees (MMRCs) are multi-disciplinary committees that convene at the state or local level to comprehensively review deaths of women during or within a year of pregnancy. This document summarizes substance use disorder findings in a recent review of MMRC data in 14 states.

This is the first in a series of articles on state policies that support or inhibit postpartum women’s (PPWs’) access to long-term recovery from opioid-use disorders (OUDs). It reviews current federal and state policies on mandatory reporting by health care professionals of a patient's substance use during pregnancy and their implications

This Spanish language fact sheet is to inform parents how to effectively talk to their young adult about the risks of underage drinking.

This section of the Rural Health Toolkit includes examples of innovative telehealth approaches to provide care for people with opioid use disorder in rural communities.

SAMHSA offers evidence-based resources to help providers screen, diagnose, and deliver integrated care to patients with co-occurring disorders.

The primary objectives of the SOURCE (Simulation of Opioid Use, Response, Consequences, and Effects) model are threefold: help the FDA and other stakeholders identify high-impact opioid-related interventions, assess potential unanticipated consequences of potential policies, and identify needs for further research.

Provides principles and recommendations for the treatment of pain syndromes with buprenorphine and buprenorphine/naloxone for clinicians.